Home > News > PGI research may help lower drug dosage
July 9th, 2007
PGI research may help lower drug dosage
Abstract:
In future, people suffering from tuberculosis (TB), cardiovasucular diseases, hypertension and other chronic diseases may not have to take drugs daily for the rest of their lives. A path breaking pre-clinical research by a team of doctors at the PGI has established a system of sustained drug delivery through nanotechnology.
The system involves encapsulating the drug in nanoparticles taken from synthetic polymers. This ensures that the drug stays in the plasma and the organs for a longer period. Secondly, since the frequency of taking drugs comes down, lesser drugs are used.
Source:
cities.expressindia.com
Bookmark:
| Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||